Skip to content
10-Q

Quarterly Report

CHINA HEALTH INDUSTRIES HOLDINGS, INC.

0001213900-24-028534

← back to feed
Filed
Apr 1, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Apr 1, 2024 65.54M sh
Shares Diluted Q2 2024 · Dec 31, 2023 65.54M sh
Shares Diluted Q2 2024 · Dec 31, 2023 65.54M sh
Shares Diluted Q2 2024 · Dec 31, 2022 65.54M sh
Shares Diluted Q2 2024 · Dec 31, 2022 65.54M sh
Operating Cash Flow Q2 2024 · Dec 31, 2023 −$35.03K
Operating Cash Flow Q2 2024 · Dec 31, 2022 $512.2K
Short Term Debt Q2 2024 · Dec 31, 2023 $35.18K
Cash And Equivalents Q2 2024 · Dec 31, 2023 $15.34K
Cash And Equivalents Q2 2024 · Jun 30, 2023 $47.25K
Stockholders Equity Q2 2024 · Dec 31, 2023 −$2.29M
Stockholders Equity Q2 2024 · Sep 30, 2023 $38.69M
Stockholders Equity Q2 2024 · Jun 30, 2023 $39.11M
Stockholders Equity Q2 2024 · Dec 31, 2022 $42.03M
Stockholders Equity Q2 2024 · Sep 30, 2022 $39.84M
Stockholders Equity Q2 2024 · Jun 30, 2022 $42.8M
Current Liabilities Q2 2024 · Dec 31, 2023 $6.56M
Current Liabilities Q2 2024 · Jun 30, 2023 $5.97M
Current Assets Q2 2024 · Dec 31, 2023 $249.45K
Current Assets Q2 2024 · Jun 30, 2023 $40.97M
Total Assets Q2 2024 · Dec 31, 2023 $4.26M
Total Assets Q2 2024 · Jun 30, 2023 $45.08M
Eps Diluted Q2 2024 · Dec 31, 2023 −$0.01
Eps Diluted Q2 2024 · Dec 31, 2023 −$0.01
Eps Diluted Q2 2024 · Dec 31, 2022 $0.01
Eps Diluted Q2 2024 · Dec 31, 2022 $0.01
Eps Basic Q2 2024 · Dec 31, 2023 −$0.01
Eps Basic Q2 2024 · Dec 31, 2023 −$0.01
Eps Basic Q2 2024 · Dec 31, 2022 $0.01
Eps Basic Q2 2024 · Dec 31, 2022 $0.01
Sga Expense Q2 2024 · Dec 31, 2023 $362.61K
Sga Expense Q2 2024 · Dec 31, 2023 $452.06K
Sga Expense Q2 2024 · Dec 31, 2022 $223.47K
Sga Expense Q2 2024 · Dec 31, 2022 $558.32K
Net Income Q2 2024 · Dec 31, 2023 −$445.56K
Net Income Q2 2024 · Dec 31, 2023 −$627.91K
Net Income Q2 2024 · Dec 31, 2022 $929.3K
Net Income Q2 2024 · Dec 31, 2022 $472.86K
Operating Income Q2 2024 · Dec 31, 2023 −$445.56K
Operating Income Q2 2024 · Dec 31, 2023 −$629.51K
Operating Income Q2 2024 · Dec 31, 2022 −$412.83K
Operating Income Q2 2024 · Dec 31, 2022 −$903.56K
Cost Of Revenue Q2 2024 · Dec 31, 2023 $46
Cost Of Revenue Q2 2024 · Dec 31, 2023 $38.35K
Cost Of Revenue Q2 2024 · Dec 31, 2022 $29.65K
Cost Of Revenue Q2 2024 · Dec 31, 2022 $29.65K
Revenue Q2 2024 · Dec 31, 2023 $46
Revenue Q2 2024 · Dec 31, 2023 $38.35K
Revenue Q2 2024 · Dec 31, 2022 $32.65K
Revenue Q2 2024 · Dec 31, 2022 $32.65K
Gross Profit Q2 2024 · Dec 31, 2022 $3.01K
Gross Profit Q2 2024 · Dec 31, 2022 $3.01K